mutex raises ¥281.6 million Series A for Reze, AI that checks Japanese medical fee claims
EditorialBy TrustList Editorial
Tokyo company mutex announced a ¥281.6 million Series A on 30 September 2026 for Reze, AI that checks hospitals’ medical fee claims for missed items and errors. An English headline gave ¥2.8 billion; the company states ¥281.6 million.
About mutex raises ¥281.6 million Series A for Reze, AI that checks Japanese medical fee claims
mutex raises ¥281.6 million Series A for Reze, AI that checks Japanese medical fee claims
30 September 2026 — mutex Inc., a Tokyo company, announced on 30 September 2026 a Series A round totalling ¥281.6 million (2億8160万円), according to its own release on PR TIMES. It puts its cumulative funding at ¥341.6 million.
Not yet independently verified. An English-language report headlined this round as ¥2.8 billion; the company’s own Japanese release states ¥281.6 million, and that is the figure used here. We will update this when it can be confirmed, and remove this note.
The round
- Amount and stage: ¥281.6 million, Series A.
- Investors named by the company: three investors, among them MEDIPAL Innovation Investment LPS, the corporate venture fund of Medipal Holdings, a large Japanese pharmaceutical wholesaler.
- Use of the money: to expand paid adoption among medical institutions and speed up product development towards fully automating claim billing.
What the company does
In Japan, hospitals and clinics bill public health insurance through monthly medical fee statements, known as receipts (レセプト). Errors and missed billable items cost providers revenue, and checking them is labour-intensive. mutex's product, Reze, works with a medical institution's existing systems, reads the claim data and flags items that could have been billed but were missed, as well as deficiencies that could lead to rejection.
Why it matters for buyers
Japanese medical institutions face staff shortages in medical administration and continuing revisions to fee schedules. Tools that check claims without replacing the electronic medical record or billing system can be adopted with less disruption. The involvement of a pharmaceutical wholesaler's fund suggests a possible route to hospitals through an existing distributor.
What to check
- Hospital administrators should ask which electronic medical record and billing systems Reze reads from, how patient data is handled under Japan's personal information rules and the health ministry's security guidelines, and how its suggestions are reviewed before submission.
- Finance teams should measure recovered revenue in a pilot against current manual checking.
Sources
Categories & features
- Japan
- Tokyo, Japan
- Asia
- Medical Billing Software
- Medical Billing
- Artificial Intelligence Software
- Venture Capital
More on TrustList
Everything here links back to the same verified catalogue. Pick your next stop.
- More JapanThe ranking for this subject
- CompaniesAgencies, consultancies and IT service providers, ranked by verified reviews.
- ProductsSoftware and SaaS with pricing, features, integrations and alternatives.
- AwardsAnnual recognition decided by verified reviews and an independent jury.
- LaunchesNew products and releases, voted up by the community every day.
- AI ModelsBenchmark scores and community ratings for every major model.
- RequestsBuyers describe what they need; vendors respond directly.
- PeopleReviewers, authors and makers with public profiles.
- ComparePut up to four listings side by side before you shortlist.